nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Biliary colic—Orlistat—obesity	0.0156	0.0277	CcSEcCtD
Levorphanol—Dyskinesia—Phenylpropanolamine—obesity	0.00925	0.0164	CcSEcCtD
Levorphanol—Personality disorder—Sibutramine—obesity	0.00851	0.0151	CcSEcCtD
Levorphanol—Dyskinesia—Diethylpropion—obesity	0.0077	0.0137	CcSEcCtD
Levorphanol—Urinary retention—Phenylpropanolamine—obesity	0.006	0.0107	CcSEcCtD
Levorphanol—Sweating—Benzphetamine—obesity	0.00599	0.0106	CcSEcCtD
Levorphanol—Dysuria—Phendimetrazine—obesity	0.00597	0.0106	CcSEcCtD
Levorphanol—Cardiac arrest—Phentermine—obesity	0.00574	0.0102	CcSEcCtD
Levorphanol—Suicide attempt—Bupropion—obesity	0.00565	0.0101	CcSEcCtD
Levorphanol—Sweating—Phendimetrazine—obesity	0.00546	0.0097	CcSEcCtD
Levorphanol—Urinary retention—Cimetidine—obesity	0.00475	0.00845	CcSEcCtD
Levorphanol—Hypokinesia—Bupropion—obesity	0.00475	0.00845	CcSEcCtD
Levorphanol—Flushing—Phendimetrazine—obesity	0.00474	0.00843	CcSEcCtD
Levorphanol—Personality disorder—Topiramate—obesity	0.00473	0.0084	CcSEcCtD
Levorphanol—Agitation—Methamphetamine—obesity	0.00465	0.00827	CcSEcCtD
Levorphanol—Agitation—Benzphetamine—obesity	0.00449	0.00798	CcSEcCtD
Levorphanol—Palpitations—Methamphetamine—obesity	0.00447	0.00795	CcSEcCtD
Levorphanol—Estradiol—FABP2—obesity	0.00435	0.284	CrCbGaD
Levorphanol—Apnoea—Sibutramine—obesity	0.00434	0.00772	CcSEcCtD
Levorphanol—Palpitations—Benzphetamine—obesity	0.00431	0.00767	CcSEcCtD
Levorphanol—Dysuria—Diethylpropion—obesity	0.00425	0.00755	CcSEcCtD
Levorphanol—Agitation—Phendimetrazine—obesity	0.00409	0.00727	CcSEcCtD
Levorphanol—Flushing—Phenylpropanolamine—obesity	0.00405	0.0072	CcSEcCtD
Levorphanol—Tachycardia—Methamphetamine—obesity	0.00403	0.00717	CcSEcCtD
Levorphanol—Thinking abnormal—Sibutramine—obesity	0.00402	0.00715	CcSEcCtD
Levorphanol—Palpitations—Phendimetrazine—obesity	0.00393	0.00699	CcSEcCtD
Levorphanol—Arrhythmia—Phenylpropanolamine—obesity	0.0039	0.00693	CcSEcCtD
Levorphanol—Tachycardia—Benzphetamine—obesity	0.00389	0.00691	CcSEcCtD
Levorphanol—Hyperhidrosis—Benzphetamine—obesity	0.00385	0.00685	CcSEcCtD
Levorphanol—Extrasystoles—Bupropion—obesity	0.00381	0.00678	CcSEcCtD
Levorphanol—Renal failure—Cimetidine—obesity	0.00379	0.00673	CcSEcCtD
Levorphanol—Insomnia—Methamphetamine—obesity	0.00374	0.00664	CcSEcCtD
Levorphanol—Tension—Phenylpropanolamine—obesity	0.00373	0.00663	CcSEcCtD
Levorphanol—Nervousness—Phenylpropanolamine—obesity	0.00369	0.00656	CcSEcCtD
Levorphanol—Dyspepsia—Methamphetamine—obesity	0.00364	0.00647	CcSEcCtD
Levorphanol—Abnormal dreams—Sibutramine—obesity	0.00364	0.00647	CcSEcCtD
Levorphanol—Insomnia—Benzphetamine—obesity	0.0036	0.00641	CcSEcCtD
Levorphanol—Suicide attempt—Topiramate—obesity	0.0036	0.0064	CcSEcCtD
Levorphanol—Tension—Phentermine—obesity	0.00357	0.00635	CcSEcCtD
Levorphanol—Tachycardia—Phendimetrazine—obesity	0.00354	0.0063	CcSEcCtD
Levorphanol—Constipation—Methamphetamine—obesity	0.00353	0.00628	CcSEcCtD
Levorphanol—Nervousness—Phentermine—obesity	0.00353	0.00628	CcSEcCtD
Levorphanol—Bradycardia—Cimetidine—obesity	0.00352	0.00626	CcSEcCtD
Levorphanol—Hyperhidrosis—Phendimetrazine—obesity	0.00351	0.00624	CcSEcCtD
Levorphanol—Dyspepsia—Benzphetamine—obesity	0.00351	0.00623	CcSEcCtD
Levorphanol—Thinking abnormal—Bupropion—obesity	0.0035	0.00623	CcSEcCtD
Levorphanol—Agitation—Phenylpropanolamine—obesity	0.00349	0.00621	CcSEcCtD
Levorphanol—Dyskinesia—Bupropion—obesity	0.00341	0.00607	CcSEcCtD
Levorphanol—Agitation—Phentermine—obesity	0.00334	0.00594	CcSEcCtD
Levorphanol—Insomnia—Phendimetrazine—obesity	0.00328	0.00584	CcSEcCtD
Levorphanol—Urticaria—Methamphetamine—obesity	0.00328	0.00584	CcSEcCtD
Levorphanol—Arrhythmia—Diethylpropion—obesity	0.00325	0.00577	CcSEcCtD
Levorphanol—Palpitations—Phentermine—obesity	0.00321	0.00571	CcSEcCtD
Levorphanol—Hyperkinesia—Sibutramine—obesity	0.00321	0.00571	CcSEcCtD
Levorphanol—Abnormal vision—Sibutramine—obesity	0.00321	0.00571	CcSEcCtD
Levorphanol—Mental disability—Sibutramine—obesity	0.00319	0.00568	CcSEcCtD
Levorphanol—Abnormal dreams—Bupropion—obesity	0.00317	0.00564	CcSEcCtD
Levorphanol—Urticaria—Benzphetamine—obesity	0.00316	0.00563	CcSEcCtD
Levorphanol—Confusional state—Phenylpropanolamine—obesity	0.00313	0.00556	CcSEcCtD
Levorphanol—Constipation—Phendimetrazine—obesity	0.00311	0.00552	CcSEcCtD
Levorphanol—Tension—Diethylpropion—obesity	0.0031	0.00552	CcSEcCtD
Levorphanol—Nervousness—Diethylpropion—obesity	0.00307	0.00546	CcSEcCtD
Levorphanol—Dry mouth—Phentermine—obesity	0.00303	0.00538	CcSEcCtD
Levorphanol—Hypokinesia—Topiramate—obesity	0.00303	0.00538	CcSEcCtD
Levorphanol—Tachycardia—Phenylpropanolamine—obesity	0.00303	0.00538	CcSEcCtD
Levorphanol—Coma—Bupropion—obesity	0.00293	0.00521	CcSEcCtD
Levorphanol—Agitation—Diethylpropion—obesity	0.00291	0.00517	CcSEcCtD
Levorphanol—Hypotension—Phenylpropanolamine—obesity	0.0029	0.00515	CcSEcCtD
Levorphanol—Tachycardia—Phentermine—obesity	0.0029	0.00515	CcSEcCtD
Levorphanol—Abdominal pain—Phendimetrazine—obesity	0.00287	0.0051	CcSEcCtD
Levorphanol—Amnesia—Sibutramine—obesity	0.00284	0.00505	CcSEcCtD
Levorphanol—Insomnia—Phenylpropanolamine—obesity	0.00281	0.00499	CcSEcCtD
Levorphanol—Hyperkinesia—Bupropion—obesity	0.0028	0.00497	CcSEcCtD
Levorphanol—Palpitations—Diethylpropion—obesity	0.0028	0.00497	CcSEcCtD
Levorphanol—Mental disability—Bupropion—obesity	0.00278	0.00495	CcSEcCtD
Levorphanol—Agitation—Cimetidine—obesity	0.00277	0.00492	CcSEcCtD
Levorphanol—Convulsion—Diethylpropion—obesity	0.00274	0.00487	CcSEcCtD
Levorphanol—Dizziness—Methamphetamine—obesity	0.00273	0.00486	CcSEcCtD
Levorphanol—Insomnia—Phentermine—obesity	0.00268	0.00477	CcSEcCtD
Levorphanol—Constipation—Phenylpropanolamine—obesity	0.00265	0.00472	CcSEcCtD
Levorphanol—Dizziness—Benzphetamine—obesity	0.00263	0.00468	CcSEcCtD
Levorphanol—Dry mouth—Diethylpropion—obesity	0.00263	0.00468	CcSEcCtD
Levorphanol—Affect lability—Sibutramine—obesity	0.00263	0.00467	CcSEcCtD
Levorphanol—Dyspepsia—Phentermine—obesity	0.00261	0.00465	CcSEcCtD
Levorphanol—Feeling abnormal—Phenylpropanolamine—obesity	0.00256	0.00454	CcSEcCtD
Levorphanol—Cardiac arrest—Sibutramine—obesity	0.00254	0.00452	CcSEcCtD
Levorphanol—Urinary retention—Sibutramine—obesity	0.00254	0.00452	CcSEcCtD
Levorphanol—Constipation—Phentermine—obesity	0.00254	0.00451	CcSEcCtD
Levorphanol—Mood swings—Sibutramine—obesity	0.00253	0.0045	CcSEcCtD
Levorphanol—Tachycardia—Diethylpropion—obesity	0.00252	0.00448	CcSEcCtD
Levorphanol—Hyperhidrosis—Diethylpropion—obesity	0.0025	0.00444	CcSEcCtD
Levorphanol—Amnesia—Bupropion—obesity	0.00248	0.00441	CcSEcCtD
Levorphanol—Confusional state—Cimetidine—obesity	0.00248	0.0044	CcSEcCtD
Levorphanol—Dizziness—Phendimetrazine—obesity	0.0024	0.00427	CcSEcCtD
Levorphanol—Tachycardia—Cimetidine—obesity	0.0024	0.00426	CcSEcCtD
Levorphanol—Lethargy—Bupropion—obesity	0.00238	0.00422	CcSEcCtD
Levorphanol—Nausea—Benzphetamine—obesity	0.00237	0.00421	CcSEcCtD
Levorphanol—Urticaria—Phentermine—obesity	0.00236	0.00419	CcSEcCtD
Levorphanol—Abdominal pain—Phentermine—obesity	0.00235	0.00417	CcSEcCtD
Levorphanol—Insomnia—Diethylpropion—obesity	0.00234	0.00415	CcSEcCtD
Levorphanol—Diplopia—Bupropion—obesity	0.00233	0.00414	CcSEcCtD
Levorphanol—Affect lability—Bupropion—obesity	0.00229	0.00407	CcSEcCtD
Levorphanol—Dyspepsia—Diethylpropion—obesity	0.00227	0.00404	CcSEcCtD
Levorphanol—Thinking abnormal—Topiramate—obesity	0.00223	0.00397	CcSEcCtD
Levorphanol—Urinary retention—Bupropion—obesity	0.00221	0.00394	CcSEcCtD
Levorphanol—Constipation—Diethylpropion—obesity	0.00221	0.00393	CcSEcCtD
Levorphanol—Mood swings—Bupropion—obesity	0.00221	0.00392	CcSEcCtD
Levorphanol—Dyskinesia—Topiramate—obesity	0.00217	0.00387	CcSEcCtD
Levorphanol—Dysuria—Sibutramine—obesity	0.00216	0.00384	CcSEcCtD
Levorphanol—Nausea—Phendimetrazine—obesity	0.00216	0.00383	CcSEcCtD
Levorphanol—Feeling abnormal—Diethylpropion—obesity	0.00213	0.00378	CcSEcCtD
Levorphanol—Constipation—Cimetidine—obesity	0.0021	0.00374	CcSEcCtD
Levorphanol—Renal failure—Orlistat—obesity	0.00209	0.00372	CcSEcCtD
Levorphanol—Urticaria—Diethylpropion—obesity	0.00205	0.00365	CcSEcCtD
Levorphanol—Dizziness—Phenylpropanolamine—obesity	0.00205	0.00365	CcSEcCtD
Levorphanol—Feeling abnormal—Cimetidine—obesity	0.00202	0.0036	CcSEcCtD
Levorphanol—Renal failure—Sibutramine—obesity	0.00202	0.0036	CcSEcCtD
Levorphanol—Sweating—Sibutramine—obesity	0.00197	0.00351	CcSEcCtD
Levorphanol—Vomiting—Phenylpropanolamine—obesity	0.00197	0.00351	CcSEcCtD
Levorphanol—Dizziness—Phentermine—obesity	0.00196	0.00349	CcSEcCtD
Levorphanol—Rash—Phenylpropanolamine—obesity	0.00196	0.00348	CcSEcCtD
Levorphanol—Dermatitis—Phenylpropanolamine—obesity	0.00195	0.00347	CcSEcCtD
Levorphanol—Vomiting—Phentermine—obesity	0.00189	0.00336	CcSEcCtD
Levorphanol—Dysuria—Bupropion—obesity	0.00188	0.00335	CcSEcCtD
Levorphanol—Bradycardia—Sibutramine—obesity	0.00188	0.00334	CcSEcCtD
Levorphanol—Rash—Phentermine—obesity	0.00187	0.00333	CcSEcCtD
Levorphanol—Dermatitis—Phentermine—obesity	0.00187	0.00332	CcSEcCtD
Levorphanol—Nausea—Phenylpropanolamine—obesity	0.00184	0.00328	CcSEcCtD
Levorphanol—Hyperkinesia—Topiramate—obesity	0.00178	0.00317	CcSEcCtD
Levorphanol—Abnormal vision—Topiramate—obesity	0.00178	0.00317	CcSEcCtD
Levorphanol—Visual impairment—Sibutramine—obesity	0.00178	0.00317	CcSEcCtD
Levorphanol—Mental disability—Topiramate—obesity	0.00177	0.00315	CcSEcCtD
Levorphanol—Nausea—Phentermine—obesity	0.00176	0.00313	CcSEcCtD
Levorphanol—Sweating—Bupropion—obesity	0.00172	0.00306	CcSEcCtD
Levorphanol—Dizziness—Diethylpropion—obesity	0.00171	0.00304	CcSEcCtD
Levorphanol—Arrhythmia—Sibutramine—obesity	0.00165	0.00293	CcSEcCtD
Levorphanol—Vomiting—Diethylpropion—obesity	0.00164	0.00292	CcSEcCtD
Levorphanol—Rash—Diethylpropion—obesity	0.00163	0.00289	CcSEcCtD
Levorphanol—Dermatitis—Diethylpropion—obesity	0.00163	0.00289	CcSEcCtD
Levorphanol—Dizziness—Cimetidine—obesity	0.00162	0.00289	CcSEcCtD
Levorphanol—Muscle spasms—Orlistat—obesity	0.0016	0.00284	CcSEcCtD
Levorphanol—Amnesia—Topiramate—obesity	0.00158	0.00281	CcSEcCtD
Levorphanol—Tension—Sibutramine—obesity	0.00158	0.00281	CcSEcCtD
Levorphanol—Nervousness—Sibutramine—obesity	0.00156	0.00278	CcSEcCtD
Levorphanol—Vomiting—Cimetidine—obesity	0.00156	0.00278	CcSEcCtD
Levorphanol—Visual impairment—Bupropion—obesity	0.00155	0.00276	CcSEcCtD
Levorphanol—Rash—Cimetidine—obesity	0.00155	0.00275	CcSEcCtD
Levorphanol—Dermatitis—Cimetidine—obesity	0.00155	0.00275	CcSEcCtD
Levorphanol—Muscle spasms—Sibutramine—obesity	0.00155	0.00275	CcSEcCtD
Levorphanol—Nausea—Diethylpropion—obesity	0.00153	0.00273	CcSEcCtD
Levorphanol—Lethargy—Topiramate—obesity	0.00151	0.00269	CcSEcCtD
Levorphanol—Flushing—Bupropion—obesity	0.00149	0.00266	CcSEcCtD
Levorphanol—Diplopia—Topiramate—obesity	0.00148	0.00264	CcSEcCtD
Levorphanol—Agitation—Sibutramine—obesity	0.00148	0.00263	CcSEcCtD
Levorphanol—Estradiol—NR1I2—obesity	0.00147	0.096	CrCbGaD
Levorphanol—Palpitations—Orlistat—obesity	0.00147	0.00261	CcSEcCtD
Levorphanol—Affect lability—Topiramate—obesity	0.00146	0.0026	CcSEcCtD
Levorphanol—Nausea—Cimetidine—obesity	0.00146	0.00259	CcSEcCtD
Levorphanol—Convulsion—Orlistat—obesity	0.00144	0.00256	CcSEcCtD
Levorphanol—Arrhythmia—Bupropion—obesity	0.00144	0.00256	CcSEcCtD
Levorphanol—Palpitations—Sibutramine—obesity	0.00142	0.00253	CcSEcCtD
Levorphanol—Urinary retention—Topiramate—obesity	0.00141	0.00251	CcSEcCtD
Levorphanol—Mood swings—Topiramate—obesity	0.00141	0.0025	CcSEcCtD
Levorphanol—Convulsion—Sibutramine—obesity	0.00139	0.00248	CcSEcCtD
Levorphanol—Dry mouth—Orlistat—obesity	0.00138	0.00246	CcSEcCtD
Levorphanol—Tension—Bupropion—obesity	0.00138	0.00245	CcSEcCtD
Levorphanol—Nervousness—Bupropion—obesity	0.00136	0.00242	CcSEcCtD
Levorphanol—Muscle spasms—Bupropion—obesity	0.00135	0.0024	CcSEcCtD
Levorphanol—Dry mouth—Sibutramine—obesity	0.00134	0.00238	CcSEcCtD
Levorphanol—Confusional state—Sibutramine—obesity	0.00132	0.00235	CcSEcCtD
Levorphanol—Hyperhidrosis—Orlistat—obesity	0.00131	0.00233	CcSEcCtD
Levorphanol—Shock—Sibutramine—obesity	0.00129	0.0023	CcSEcCtD
Levorphanol—Agitation—Bupropion—obesity	0.00129	0.00229	CcSEcCtD
Levorphanol—Tachycardia—Sibutramine—obesity	0.00128	0.00228	CcSEcCtD
Levorphanol—Hyperhidrosis—Sibutramine—obesity	0.00127	0.00226	CcSEcCtD
Levorphanol—Palpitations—Bupropion—obesity	0.00124	0.0022	CcSEcCtD
Levorphanol—Insomnia—Orlistat—obesity	0.00123	0.00218	CcSEcCtD
Levorphanol—Hypotension—Sibutramine—obesity	0.00123	0.00218	CcSEcCtD
Levorphanol—Estrone—ESR2—obesity	0.00122	0.0798	CrCbGaD
Levorphanol—Convulsion—Bupropion—obesity	0.00121	0.00216	CcSEcCtD
Levorphanol—Dysuria—Topiramate—obesity	0.0012	0.00213	CcSEcCtD
Levorphanol—Dyspepsia—Orlistat—obesity	0.00119	0.00212	CcSEcCtD
Levorphanol—Insomnia—Sibutramine—obesity	0.00119	0.00211	CcSEcCtD
Levorphanol—Dry mouth—Bupropion—obesity	0.00117	0.00208	CcSEcCtD
Levorphanol—Dyspepsia—Sibutramine—obesity	0.00116	0.00205	CcSEcCtD
Levorphanol—Confusional state—Bupropion—obesity	0.00115	0.00205	CcSEcCtD
Levorphanol—Shock—Bupropion—obesity	0.00113	0.002	CcSEcCtD
Levorphanol—Renal failure—Topiramate—obesity	0.00112	0.002	CcSEcCtD
Levorphanol—Constipation—Sibutramine—obesity	0.00112	0.002	CcSEcCtD
Levorphanol—Feeling abnormal—Orlistat—obesity	0.00112	0.00199	CcSEcCtD
Levorphanol—Tachycardia—Bupropion—obesity	0.00112	0.00199	CcSEcCtD
Levorphanol—Estrone—SHBG—obesity	0.00112	0.0728	CrCbGaD
Levorphanol—Gastrointestinal pain—Orlistat—obesity	0.00111	0.00197	CcSEcCtD
Levorphanol—Hyperhidrosis—Bupropion—obesity	0.00111	0.00197	CcSEcCtD
Levorphanol—Feeling abnormal—Sibutramine—obesity	0.00108	0.00192	CcSEcCtD
Levorphanol—Urticaria—Orlistat—obesity	0.00108	0.00192	CcSEcCtD
Levorphanol—Gastrointestinal pain—Sibutramine—obesity	0.00107	0.00191	CcSEcCtD
Levorphanol—Abdominal pain—Orlistat—obesity	0.00107	0.00191	CcSEcCtD
Levorphanol—Hypotension—Bupropion—obesity	0.00107	0.0019	CcSEcCtD
Levorphanol—Bradycardia—Topiramate—obesity	0.00104	0.00186	CcSEcCtD
Levorphanol—Urticaria—Sibutramine—obesity	0.00104	0.00185	CcSEcCtD
Levorphanol—Abdominal pain—Sibutramine—obesity	0.00104	0.00185	CcSEcCtD
Levorphanol—Insomnia—Bupropion—obesity	0.00104	0.00184	CcSEcCtD
Levorphanol—Dyspepsia—Bupropion—obesity	0.00101	0.00179	CcSEcCtD
Levorphanol—Visual impairment—Topiramate—obesity	0.000989	0.00176	CcSEcCtD
Levorphanol—Constipation—Bupropion—obesity	0.000979	0.00174	CcSEcCtD
Levorphanol—Pruritus—Orlistat—obesity	0.00096	0.00171	CcSEcCtD
Levorphanol—Flushing—Topiramate—obesity	0.000952	0.00169	CcSEcCtD
Levorphanol—Feeling abnormal—Bupropion—obesity	0.000943	0.00168	CcSEcCtD
Levorphanol—Gastrointestinal pain—Bupropion—obesity	0.000936	0.00166	CcSEcCtD
Levorphanol—Pruritus—Sibutramine—obesity	0.000929	0.00165	CcSEcCtD
Levorphanol—Estradiol—ESR2—obesity	0.000927	0.0605	CrCbGaD
Levorphanol—Urticaria—Bupropion—obesity	0.000909	0.00162	CcSEcCtD
Levorphanol—Abdominal pain—Bupropion—obesity	0.000905	0.00161	CcSEcCtD
Levorphanol—Dizziness—Orlistat—obesity	0.000897	0.00159	CcSEcCtD
Levorphanol—Tension—Topiramate—obesity	0.000877	0.00156	CcSEcCtD
Levorphanol—Dizziness—Sibutramine—obesity	0.000868	0.00154	CcSEcCtD
Levorphanol—Nervousness—Topiramate—obesity	0.000868	0.00154	CcSEcCtD
Levorphanol—Vomiting—Orlistat—obesity	0.000862	0.00153	CcSEcCtD
Levorphanol—Muscle spasms—Topiramate—obesity	0.000859	0.00153	CcSEcCtD
Levorphanol—Rash—Orlistat—obesity	0.000855	0.00152	CcSEcCtD
Levorphanol—Dermatitis—Orlistat—obesity	0.000854	0.00152	CcSEcCtD
Levorphanol—Estradiol—SHBG—obesity	0.000846	0.0551	CrCbGaD
Levorphanol—Estradiol—SLC22A1—obesity	0.000835	0.0544	CrCbGaD
Levorphanol—Vomiting—Sibutramine—obesity	0.000835	0.00148	CcSEcCtD
Levorphanol—Rash—Sibutramine—obesity	0.000828	0.00147	CcSEcCtD
Levorphanol—Dermatitis—Sibutramine—obesity	0.000827	0.00147	CcSEcCtD
Levorphanol—Agitation—Topiramate—obesity	0.000821	0.00146	CcSEcCtD
Levorphanol—Pruritus—Bupropion—obesity	0.00081	0.00144	CcSEcCtD
Levorphanol—Nausea—Orlistat—obesity	0.000806	0.00143	CcSEcCtD
Levorphanol—Palpitations—Topiramate—obesity	0.00079	0.0014	CcSEcCtD
Levorphanol—Nausea—Sibutramine—obesity	0.00078	0.00139	CcSEcCtD
Levorphanol—Convulsion—Topiramate—obesity	0.000774	0.00138	CcSEcCtD
Levorphanol—Dizziness—Bupropion—obesity	0.000757	0.00135	CcSEcCtD
Levorphanol—Estrone—ESR1—obesity	0.000754	0.0491	CrCbGaD
Levorphanol—Dry mouth—Topiramate—obesity	0.000744	0.00132	CcSEcCtD
Levorphanol—Estradiol—AR—obesity	0.000742	0.0484	CrCbGaD
Levorphanol—Confusional state—Topiramate—obesity	0.000735	0.00131	CcSEcCtD
Levorphanol—Vomiting—Bupropion—obesity	0.000728	0.00129	CcSEcCtD
Levorphanol—Rash—Bupropion—obesity	0.000722	0.00128	CcSEcCtD
Levorphanol—Dermatitis—Bupropion—obesity	0.000721	0.00128	CcSEcCtD
Levorphanol—Shock—Topiramate—obesity	0.000717	0.00128	CcSEcCtD
Levorphanol—Tachycardia—Topiramate—obesity	0.000712	0.00127	CcSEcCtD
Levorphanol—Hyperhidrosis—Topiramate—obesity	0.000705	0.00125	CcSEcCtD
Levorphanol—Hypotension—Topiramate—obesity	0.000681	0.00121	CcSEcCtD
Levorphanol—Nausea—Bupropion—obesity	0.00068	0.00121	CcSEcCtD
Levorphanol—Dextromethorphan—SLC6A4—obesity	0.000665	0.0433	CrCbGaD
Levorphanol—Insomnia—Topiramate—obesity	0.000659	0.00117	CcSEcCtD
Levorphanol—Dyspepsia—Topiramate—obesity	0.000642	0.00114	CcSEcCtD
Levorphanol—Dextromethorphan—CYP2E1—obesity	0.000636	0.0415	CrCbGaD
Levorphanol—Constipation—Topiramate—obesity	0.000624	0.00111	CcSEcCtD
Levorphanol—Estrone—CYP2E1—obesity	0.000611	0.0398	CrCbGaD
Levorphanol—Feeling abnormal—Topiramate—obesity	0.000601	0.00107	CcSEcCtD
Levorphanol—Gastrointestinal pain—Topiramate—obesity	0.000596	0.00106	CcSEcCtD
Levorphanol—Urticaria—Topiramate—obesity	0.000579	0.00103	CcSEcCtD
Levorphanol—Abdominal pain—Topiramate—obesity	0.000576	0.00102	CcSEcCtD
Levorphanol—Estradiol—ESR1—obesity	0.000571	0.0372	CrCbGaD
Levorphanol—Pruritus—Topiramate—obesity	0.000516	0.000917	CcSEcCtD
Levorphanol—Dizziness—Topiramate—obesity	0.000482	0.000857	CcSEcCtD
Levorphanol—Vomiting—Topiramate—obesity	0.000464	0.000824	CcSEcCtD
Levorphanol—Rash—Topiramate—obesity	0.00046	0.000817	CcSEcCtD
Levorphanol—Dermatitis—Topiramate—obesity	0.000459	0.000817	CcSEcCtD
Levorphanol—Nausea—Topiramate—obesity	0.000433	0.00077	CcSEcCtD
Levorphanol—Estrone—ALB—obesity	0.000336	0.0219	CrCbGaD
Levorphanol—Estradiol—ALB—obesity	0.000254	0.0166	CrCbGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CG—obesity	7.37e-05	0.000174	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PARP1—obesity	7.28e-05	0.000172	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GHRL—obesity	7.28e-05	0.000172	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—POMC—obesity	7.26e-05	0.000172	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PRL—obesity	7.24e-05	0.000172	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NPY—obesity	7.23e-05	0.000171	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—DRD4—obesity	7.22e-05	0.000171	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IAPP—obesity	7.19e-05	0.00017	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOC3—obesity	7.19e-05	0.00017	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STK11—obesity	7.14e-05	0.000169	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL2—obesity	7.1e-05	0.000168	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PLG—obesity	7.06e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—RHOA—obesity	7.05e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AGT—obesity	7.04e-05	0.000167	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—POMC—obesity	7.01e-05	0.000166	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—F2—obesity	6.99e-05	0.000166	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PRKCB—obesity	6.99e-05	0.000166	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT2—obesity	6.98e-05	0.000165	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HTR1B—obesity	6.98e-05	0.000165	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CRH—obesity	6.98e-05	0.000165	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3R1—obesity	6.97e-05	0.000165	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SDC1—obesity	6.9e-05	0.000163	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CNR1—obesity	6.89e-05	0.000163	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FOXO3—obesity	6.89e-05	0.000163	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PRKCD—obesity	6.88e-05	0.000163	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ADRB2—obesity	6.87e-05	0.000163	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKR1C3—obesity	6.79e-05	0.000161	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TCF7L2—obesity	6.77e-05	0.00016	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SOCS1—obesity	6.77e-05	0.00016	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT2—obesity	6.74e-05	0.00016	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—HTR2A—obesity	6.74e-05	0.00016	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—C3—obesity	6.73e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—DRD2—obesity	6.72e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CD—obesity	6.71e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CG—obesity	6.69e-05	0.000158	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SOCS3—obesity	6.68e-05	0.000158	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GCG—obesity	6.66e-05	0.000158	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTPN1—obesity	6.66e-05	0.000158	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NPS—obesity	6.62e-05	0.000157	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GNB3—obesity	6.54e-05	0.000155	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PRKCB—obesity	6.5e-05	0.000154	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—F2—obesity	6.5e-05	0.000154	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HTR2C—obesity	6.49e-05	0.000154	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—DRD1—obesity	6.49e-05	0.000154	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CD—obesity	6.47e-05	0.000153	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—TYK2—obesity	6.45e-05	0.000153	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CB—obesity	6.44e-05	0.000152	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF2—obesity	6.43e-05	0.000152	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—RHOA—obesity	6.4e-05	0.000152	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AGT—obesity	6.39e-05	0.000151	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GNAS—obesity	6.37e-05	0.000151	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—POMC—obesity	6.37e-05	0.000151	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PRL—obesity	6.35e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3R1—obesity	6.33e-05	0.00015	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NTRK2—obesity	6.31e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADRB1—obesity	6.28e-05	0.000149	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STK11—obesity	6.26e-05	0.000148	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOB—obesity	6.24e-05	0.000148	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL2—obesity	6.23e-05	0.000148	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CG—obesity	6.22e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PLG—obesity	6.19e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—RHOA—obesity	6.18e-05	0.000146	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PARP1—obesity	6.15e-05	0.000146	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GHRL—obesity	6.15e-05	0.000146	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT2—obesity	6.12e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3R1—obesity	6.11e-05	0.000145	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—DRD4—obesity	6.1e-05	0.000144	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL5—obesity	6.09e-05	0.000144	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FOXO3—obesity	6.04e-05	0.000143	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ADRB2—obesity	6.02e-05	0.000143	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LPL—obesity	5.96e-05	0.000141	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SOCS1—obesity	5.93e-05	0.000141	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—POMC—obesity	5.93e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FOXO1—obesity	5.91e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—F2—obesity	5.91e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PRKCB—obesity	5.91e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RPS6KB1—obesity	5.9e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CD—obesity	5.88e-05	0.000139	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SOCS3—obesity	5.86e-05	0.000139	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CB—obesity	5.84e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CNR1—obesity	5.82e-05	0.000138	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GNB3—obesity	5.74e-05	0.000136	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TCF7L2—obesity	5.72e-05	0.000136	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT2—obesity	5.7e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—DRD2—obesity	5.68e-05	0.000135	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—TYK2—obesity	5.66e-05	0.000134	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CG—obesity	5.65e-05	0.000134	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CB—obesity	5.64e-05	0.000134	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF2—obesity	5.63e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GCG—obesity	5.63e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTPN1—obesity	5.63e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—RHOA—obesity	5.61e-05	0.000133	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GNAS—obesity	5.59e-05	0.000132	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3R1—obesity	5.55e-05	0.000132	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PRKCD—obesity	5.49e-05	0.00013	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CD—obesity	5.47e-05	0.00013	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOB—obesity	5.47e-05	0.00013	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—POMC—obesity	5.38e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HTR2A—obesity	5.37e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRL—obesity	5.37e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—C3—obesity	5.36e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL5—obesity	5.34e-05	0.000127	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STK11—obesity	5.29e-05	0.000125	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL2—obesity	5.26e-05	0.000125	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PLG—obesity	5.23e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LPL—obesity	5.22e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—RHOA—obesity	5.22e-05	0.000124	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FOXO1—obesity	5.19e-05	0.000123	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RPS6KB1—obesity	5.18e-05	0.000123	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT2—obesity	5.17e-05	0.000123	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3R1—obesity	5.17e-05	0.000122	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CB—obesity	5.13e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FOXO3—obesity	5.1e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IRS2—obesity	5.1e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGT—obesity	5.1e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADRB2—obesity	5.09e-05	0.000121	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SOCS1—obesity	5.01e-05	0.000119	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LEP—obesity	4.99e-05	0.000118	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOE—obesity	4.99e-05	0.000118	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CD—obesity	4.97e-05	0.000118	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SOCS3—obesity	4.95e-05	0.000117	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CAV1—obesity	4.95e-05	0.000117	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOA1—obesity	4.94e-05	0.000117	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GNB3—obesity	4.85e-05	0.000115	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PRKCD—obesity	4.81e-05	0.000114	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—TYK2—obesity	4.78e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CB—obesity	4.77e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ESR1—obesity	4.77e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF2—obesity	4.76e-05	0.000113	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—RHOA—obesity	4.74e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GNAS—obesity	4.72e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HTR2A—obesity	4.71e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—F2—obesity	4.71e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PRKCB—obesity	4.71e-05	0.000112	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—C3—obesity	4.7e-05	0.000111	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3R1—obesity	4.69e-05	0.000111	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—BAD—obesity	4.65e-05	0.00011	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOB—obesity	4.62e-05	0.000109	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL5—obesity	4.51e-05	0.000107	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CG—obesity	4.51e-05	0.000107	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IRS2—obesity	4.47e-05	0.000106	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGT—obesity	4.47e-05	0.000106	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IRS1—obesity	4.45e-05	0.000105	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LPL—obesity	4.41e-05	0.000105	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FOXO1—obesity	4.38e-05	0.000104	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LEP—obesity	4.38e-05	0.000104	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOE—obesity	4.38e-05	0.000104	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RPS6KB1—obesity	4.37e-05	0.000104	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CAV1—obesity	4.34e-05	0.000103	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CB—obesity	4.33e-05	0.000103	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOA1—obesity	4.33e-05	0.000103	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—POMC—obesity	4.29e-05	0.000102	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—INS—obesity	4.27e-05	0.000101	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL2—obesity	4.2e-05	9.94e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ESR1—obesity	4.18e-05	9.9e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PRKCB—obesity	4.13e-05	9.78e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—F2—obesity	4.13e-05	9.78e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF1—obesity	4.13e-05	9.77e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT2—obesity	4.12e-05	9.76e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—BAD—obesity	4.08e-05	9.66e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKCD—obesity	4.07e-05	9.63e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HTR2A—obesity	3.98e-05	9.43e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—C3—obesity	3.97e-05	9.41e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CD—obesity	3.96e-05	9.38e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CG—obesity	3.95e-05	9.36e-05	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CA—obesity	3.92e-05	9.29e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SERPINE1—obesity	3.92e-05	9.28e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IRS1—obesity	3.91e-05	9.25e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TYK2—obesity	3.81e-05	9.03e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IRS2—obesity	3.78e-05	8.96e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RHOA—obesity	3.78e-05	8.95e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGT—obesity	3.78e-05	8.94e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—POMC—obesity	3.76e-05	8.91e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3R1—obesity	3.74e-05	8.86e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOS3—obesity	3.74e-05	8.86e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—INS—obesity	3.74e-05	8.86e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOE—obesity	3.7e-05	8.76e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LEP—obesity	3.7e-05	8.76e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL2—obesity	3.68e-05	8.72e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CAV1—obesity	3.67e-05	8.68e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOA1—obesity	3.66e-05	8.66e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1—obesity	3.62e-05	8.57e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT2—obesity	3.62e-05	8.56e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CA—obesity	3.56e-05	8.44e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ESR1—obesity	3.53e-05	8.37e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—F2—obesity	3.49e-05	8.26e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKCB—obesity	3.49e-05	8.26e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CD—obesity	3.47e-05	8.23e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MTOR—obesity	3.45e-05	8.18e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CB—obesity	3.45e-05	8.18e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—BAD—obesity	3.45e-05	8.17e-05	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CA—obesity	3.44e-05	8.15e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SERPINE1—obesity	3.44e-05	8.14e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TYK2—obesity	3.34e-05	7.91e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CG—obesity	3.34e-05	7.91e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RHOA—obesity	3.31e-05	7.85e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IRS1—obesity	3.3e-05	7.82e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3R1—obesity	3.28e-05	7.77e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOS3—obesity	3.28e-05	7.77e-05	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—obesity	3.21e-05	7.59e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—POMC—obesity	3.18e-05	7.53e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—INS—obesity	3.16e-05	7.49e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—obesity	3.16e-05	7.47e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CA—obesity	3.12e-05	7.4e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL2—obesity	3.11e-05	7.37e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1—obesity	3.06e-05	7.24e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT2—obesity	3.06e-05	7.24e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MTOR—obesity	3.03e-05	7.17e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CB—obesity	3.03e-05	7.17e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—obesity	3e-05	7.11e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CD—obesity	2.94e-05	6.95e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK8—obesity	2.92e-05	6.91e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—obesity	2.91e-05	6.89e-05	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CA—obesity	2.91e-05	6.89e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SERPINE1—obesity	2.9e-05	6.88e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TYK2—obesity	2.82e-05	6.69e-05	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—obesity	2.81e-05	6.66e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RHOA—obesity	2.8e-05	6.63e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOS3—obesity	2.77e-05	6.57e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3R1—obesity	2.77e-05	6.57e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—obesity	2.77e-05	6.55e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT3—obesity	2.67e-05	6.32e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CA—obesity	2.64e-05	6.25e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—obesity	2.63e-05	6.23e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK8—obesity	2.56e-05	6.06e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CB—obesity	2.56e-05	6.06e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MTOR—obesity	2.56e-05	6.06e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—obesity	2.55e-05	6.05e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MYC—obesity	2.48e-05	5.87e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFB1—obesity	2.47e-05	5.86e-05	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—obesity	2.38e-05	5.63e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT3—obesity	2.34e-05	5.54e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—obesity	2.34e-05	5.54e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—obesity	2.22e-05	5.27e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MYC—obesity	2.17e-05	5.15e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFB1—obesity	2.17e-05	5.14e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK8—obesity	2.16e-05	5.12e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—obesity	2.16e-05	5.11e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CA—obesity	2.1e-05	4.99e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT3—obesity	1.98e-05	4.68e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—obesity	1.86e-05	4.41e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CA—obesity	1.85e-05	4.37e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MYC—obesity	1.84e-05	4.35e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFB1—obesity	1.83e-05	4.34e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—obesity	1.72e-05	4.07e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—obesity	1.63e-05	3.87e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CA—obesity	1.56e-05	3.69e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—obesity	1.51e-05	3.57e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—obesity	1.38e-05	3.27e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—obesity	1.27e-05	3.02e-05	CbGpPWpGaD
